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E-mail address: vacratsi@uwindsor.ca (P.O. VacratMyotubularin related protein 2 (MTMR2) is a member of the myotubularin family of phosphoinosi-
tide lipid phosphatases. Although MTMR2 dephosphorylates the phosphoinositides PI(3)P and
PI(3,5)P2, the phosphoinositide binding proteins that are regulated by MTMR2 are poorly character-
ized. In this study, phosphoinositide afﬁnity chromatography coupled to mass spectrometry identi-
ﬁed receptor mediated endocytosis 8 (RME-8) as a novel PI(3)P binding protein. RME-8 co-localized
with the PI(3)P marker DsRed-FYVE, while the N-terminal region of RME-8 is required for PI(3)P and
PI(3,5)P2 binding in vitro. Depletion of PI(3)P by MTMR2 S58A or wortmannin treatment attenuated
RME-8 endosomal localization and co-localization with EGFR on early endosomes. Our results sug-
gest a model in which the localization of RME-8 to endosomal compartments is spatially mediated
by PI(3)P binding and temporally regulated by MTMR2 activity.
Structured summary of protein interactions:
EGFR and LAMP1 colocalize by ﬂuorescence microscopy (View interaction)
RME8, EGFR and Rab5 colocalize by ﬂuorescence microscopy (View interaction)
RME8 and EGFR colocalize by ﬂuorescence microscopy (View interaction)
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The phosphatidylinositol phosphate (PIP) isoforms PI(3)P and
PI(3,5)P2 are known to serve as membrane targeting ligands for
proteins that are essential for cellular membrane trafﬁcking pro-
cesses. These lipid–protein interactions function in translocating
signaling proteins to discrete membrane locations where they
can properly respond to extracellular stimuli [1]. The signaling
pathways are subsequently turned off through the dephosphoryla-
tion of the PIPs.
The MTMR family of lipid phosphatases, composed of active and
inactive subgroups, represents the largest protein tyrosine phos-chemical Societies. Published by E
desorption ionization-mass
rosine phosphatase; RME-8,
cognate 70; MTMR2, myotu-
hosphate; PI(3)K, phosphoin-
ptor; CMT4B1, Charcot-Marie
sis).phatase (PTP) subfamily conserved from yeast to humans [2,3]. Ini-
tially, MTM1 was the ﬁrst family member shown to
dephosphorylate the D3 position of PI(3)P in vitro and in vivo
[4,5]. Subsequently, all active members tested have been shown
to also be PI(3)P phosphatases [6,7]. Furthermore, there is accumu-
lating evidence that MTMs can also utilize PI(3,5)P2 as a physio-
logic substrate [6,8,9]. Therefore, MTMs are thought to
antagonize effector molecules that utilize PI(3)P or PI(3,5)P2 as tar-
geting ligands and/or allosteric activators.
Mutations in mtmr2, on chromosome 11q22, have been shown
to cause the neurodegenerative disorder, Charcot-Marie-tooth dis-
ease 4B1 (CMT4B1) [10]. CMT4B1 is an autosomal recessive aggres-
sive form of CMT, characterized by abnormally folded myelin
sheaths, inadequate nerve signaling to muscles, and eventual mus-
cle weakness and atrophy [11]. While the pathophysiological con-
sequence resulting from the loss of myotubularin related protein 2
(MTMR2) function is well established, how MTMR2 participates in
trafﬁcking events remains poorly understood. Recently we have
characterized an N-terminal MTMR2 phosphorylation site at posi-
tion Ser58 that dramatically regulates MTMR2 endosomal localiza-
tion and thus access to its lipid substrates [12]. A phosphorylationlsevier B.V. All rights reserved.
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localization and an enhanced ability to deplete PI(3)P from endo-
somal vesicles signifying that reversible phosphorylation is a crit-
ical mechanism regulating the activities of MTMR2.
The biological pathways affected by MTMR proteins remain
inadequately characterized. This task has proven difﬁcult due to
the poor understanding of PIP binding domains that speciﬁcally
interact with the PIP isoforms that MTMRs target [1]. In this study,
we utilized a proteomic approach using immobilized PIP isoforms
to identify novel PIP binding proteins. Herein, we describe the
identiﬁcation of receptor mediated endocytosis 8 (RME-8) as a no-
vel PI(3)P binding protein whose lipid binding activity is affected
by MTMR2.s2. Materials and methods
2.1. Identiﬁcation of novel PIP binding proteins by mass spectrometry
Immobilized PIP isoforms (Echelon) were prepared for afﬁnity
chromatography according to the manufacturer’s protocol. RT4-
D6P2T Schwann cells (6  107) were grown to 80% conﬂuency,
lysed and the soluble lysate ﬁltered. The cellular lysates was
pre-cleared with PI control beads followed by the loading of
10 mg of total protein to either PIP, PI(3)P, PI(3,5)P2, or PI(5)P re-
sin. The lipid pulldown was performed by batch method over-
night at 4 C. Following rigorous washing conditions the bound
proteins were eluted in SDS–PAGE loading buffer and analyzed
by SDS–PAGE and silver staining. Protein bands of interest were
excised and in-gel digested with trypsin. The extracted pools of
tryptic peptides were then analyzed by matrix-assisted laser
desorption ionization (MALDI)-time of ﬂight (TOF) mass spec-
trometry (MS) for protein identiﬁcation as described previously
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*2.2. Cell culture and transfection
HeLa and HEK293 cells were utilized for their reproducible
transfection efﬁciency and were maintained in DMEM/ F-12 sup-
plemented with 10% FBS, 1% penicillin/streptomycin and main-
tained at 37 C with 5% CO2. Cells were transiently transfected
with expression vectors encoding FLAG tagged-MTMR2 S58A [12]
and GFP-RME-8 variants [14] using FuGene HD Transfection Re-
agent (Roche) according to the manufacturer’s protocol. The
DsRed-FYVE construct was created by PCR ampliﬁcation of the se-
quence encoding the FYVE domain of EEA1 followed by cloning
into the pDsRed expression vector (Clonetech). Where indicated,
wortmannin treatment (1 lM) was for 1 h at 37 C.25-
19-
Fig. 1. PIP lipid pull down from Schwann cells. Cell lysates were prepared from rat
RT4-D6P2T Schwann cells (6  107). Approximately 10 mg of total protein was
subjected to afﬁnity chromatography on the indicated immobilized PIP resin.
Following stringent washing conditions, the samples were resolved on a 12% SDS–
PAGE gel and silver stained. Asterisks indicate the protein bands of interest which
were excised and identiﬁed by mass spectrometry.2.3. PIP pulldown
HEK293 cells were transiently transfected with GFP-RME-8
variants for 24 h and lysed in modiﬁed RIPA buffer (50 mM Tris–
HCl pH 7.4, 1% Nonidet P-40, 76 mM NaCl, 2 mM EGTA, 10% Glyc-
erol) supplemented with protease inhibitors PMSF (1 mM) and
aprotinin (1 mM). Cell lysates were incubated with PI(3)P,
PI(3,5)P2 and PIP conjugated resin (Echelon Research Laboratories)
overnight at 4 C. The samples were washed 3 times with 10 mM
HEPES pH 7.4, 150 mM NaCl, 0.25% NP-40 and resuspended in
SDS–PAGE loading dye. The protein samples were separated on
an 8% SDS–PAGE, transferred to a PVDF membrane and immuno-
blotted with goat anti-GFP (Rockland) as the primary antibody
and rabbit-anti goat HRP (Rockland) as the secondary antibody.
Proteins were visualized using Super Signal West Femto reagent
(Thermo scientiﬁc).2.4. Immunoﬂourescence and image acquisition
Following transient transfection, Hela cells were ﬁxed at room
temperature with 3.7% paraformaldehyde in PBS. Cells were then
permeabilized with 0.15% Triton X-100 in PBS at room temperature
for 2 min and blocked for 1 h in 5% BSA (Sigma). Cells were incu-
bated with mouse anti-FLAG antibody (Sigma–Aldrich) or rabbit
anti-EGFR (Santa Cruz Biotechnology) in TBST. Following washing,
cells were incubated with either Alexa 568 goat anti-mouse, Alexa
350 donkey anti-rabbit (Invitrogen) or ﬂuorescein goat anti-rabbit
(Vector laboratories) secondary antibodies. All the incubations
were performed at room temperature for 1 h followed by three
5 min washes in TBST. Hoechst 33342 (Molecular Probes) was used
to stain the nuclei and Slowfade Antifade kit was used to mount
the slides (Molecular Probes) according to the manufacturer’s pro-
tocol. Images were captured with a Q-imaging CCD camera on a
Leica DMIRB microscope using the Northern Eclipse software and
Abobe Photoshop 7.0.
3. Results and discussion
3.1. Isolation of the RME-8/Hsc70 complex from Schwann cells using
PI(3)P afﬁnity chromatography
Knowledge of proteins affected by the lipid phosphatase activ-
ity of MTMR2 is poorly deﬁned. To identify putative targets of
MTMR2, a pull down assay was performed using disease relevant
Schwann cells and conjugated PI(3)P and PI(3,5)P2 beads. Beads
conjugated with the enzymatic products of MTMR2, PI and
PI(5)P, were also included. The PIP beads were incubated with
equal concentrations of cellular lysate from rat RT4-D6P2T Schw-
1724 B. Xhabija et al. / FEBS Letters 585 (2011) 1722–1728ann cells followed by extensive washing. Following elution in SDS–
PAGE loading dye, the proteins were separated by SDS–PAGE and
detected by silver staining (Fig. 1). Several protein bands appeared
speciﬁc to the PIP isoforms including two protein bands observed
at molecular weights of approximately 205 and 70 kDa that were
speciﬁc for PI(3)P and PI(3,5)P2 (indicated by asterisks).
Protein bands of interest were excised and in-gel digested with
trypsin. The extracted pools of tryptic peptides were then analyzed
by MALDI-TOF MS/MS for protein identiﬁcation. The 205 kDa band
was identiﬁed as receptor-mediated endocytosis 8 (RME-8) and
the 70 kDa band was identiﬁed as heat shock cognate 70 (Hsc70)
(Fig. 2). At least 10 peptides from each trypsin digest were sub-
jected to MS/MS analysis to obtain unambiguous identiﬁcation.
The high sequence coverage was particular important in the case
of Hsc70 in order to distinguish from closely related homologues.
Notably, the 200 kDa band present in the PI(5)P sample (Fig. 1)
was identiﬁed as pyruvate decarboxylase (data not shown).
The identiﬁcation of RME-8 and Hsc70 is intriguing since these
two proteins in a variety of organisms and cell types have been
shown to function in a complex and regulate receptor-mediated
and ﬂuid-phase endocytosis [15–17]. Furthermore, Drosophila
RME-8 and Hsc70 have been shown to interact in vitro [16], while
human RME-8, through its J-domain, has been shown to directly
bind to Hsc70 in an ATP dependent manner [17].
3.2. PI3P is required for the association between RME-8 and early
endosomes
It has been demonstrated that RME-8 can localize to mem-
brane vesicles including early endosomes [14,18]. Our current175.09
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Fig. 2. Identiﬁcation of putative PIP binding proteins by MALDI-MS/MS. Following trypsi
(A) Shown is a MS/MS spectrum for the precursor ion 1957 m/z. Fragment ion series ana
spectrum for precursor ion 1691 m/z. Fragment ion series analysis resulted in identiﬁcaproteomic results suggest that RME-8 can also interact with the
substrates of MTMR2, such as PI(3)P, which are present on mem-
brane vesicles such as endosomes. To test if PI(3)P is required for
its endosomal localization, we examined the ability of RME-8 to
co-localize with a well characterized reporter for PI(3)P enriched
endosomes, DsRed-FYVE [19]. As shown in Fig. 3A, RME-8
displayed strong co-staining with DsRed-FYVE conﬁrming that
RME-8 positive vesicles contain PI(3)P. Cells were then treated
with the phosphoinositide 3-kinase (PI(3)K) inhibitor wortman-
nin to investigate the requirement of PI(3)P for the membrane
vesicle localization of RME-8. Wortmannin-induced PI(3)P
depletion led to a strong reduction in the endosomal staining
pattern of RME-8. Thus, in addition to interacting with PI(3)P
beads in vitro, RME-8 associates with PI(3)P containing vesicles
in vivo.
RME-8 possesses a DnaJ domain in the C-terminal half of the
protein that is responsible for interacting with Hsc70 [15,16].
The C-terminal region also mediates the reported interaction be-
tween RME-8 and sorting nexin 1[18]. On the other hand, the N-
terminal region has been shown to mediate the membrane local-
ization of RME-8 [14]. Likewise, PIP pull down assays were per-
formed with RME-8 deletion constructs to determine which
RME-8 region was responsible for the observed PI(3)P and
PI(3,5)P2 binding. The results showed that full length RME-8
and a variant encompassing all but the last 425 amino acids were
able to associate with PI(3)P and PI(3,5)P2. In contrast, deletion of
the ﬁrst 453 amino acids completely abolished binding to PI(3)P
and PI(3,5)P2 (Fig. 4). Taken together, our results strongly suggest
that RME-8 is a novel PI(3)P binding protein both in vitro and in
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Fig. 3. Rme-8 colocalizes with vesicles containing PI(3)P. Hela cells were co-transfected with GFP-RME-8 and DsRed-FYVE expression vectors and analyzed by
immunoﬂuorescence microscopy. Localization pattern of GFP-RME-8 without wortmannin treatment (A) and with wortmannin treatment (B) is shown. The merged images
are depicted in the right panel showing partial overlap of GFP-RME-8 and DsRed-FYVE localization without wortmannin treatment and dispersed localization with
wortmannin treatment. Images were taken with 40X objective using a ﬂuorescence microscope. Bars, 15 lm.
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endosome
We have recently discovered that MTMR2 is highly phosphory-
lated on Ser58 which sequesters MTMR2 in the cytoplasm and lim-
its access to its lipid substrates [12]. Conversely, a phosphorylation
deﬁcient mutant, MTMR2 S58A, is capable of localizing to endo-
somal vesicles and depleting PI(3)P. Therefore, to address whether
the PI(3)P binding ability of RME-8 could be affected by MTMR2,
RME-8 was co-expressed with MTMR2 S58A and the integrity of
the RME-8 endosomal pattern was analyzed by immunoﬂuores-
cent microscopy. When overexpressed alone, GFP-RME-8 and
MTMR2 S58A both exhibited the characteristic punctate endo-
somal localization pattern (Fig. 5A and B, left panels). Strikingly,
co-expression of MTMR2 S58A resulted in signiﬁcant loss of the
RME-8 endosomal localization pattern (Fig. 5A, upper right panel),
as did treatment with wortmannin (Fig. 5B, right panel). Further-
more, expression of a catalytically inactive variant (MTMR2
S58A.C417S) failed to disrupt the endosomal localization pattern
of RME-8 (Fig. 5A, lower right panel), suggesting that the associa-
tion of RME-8 with PI(3)P rich vesicles can be disrupted by the
phosphatase activity of MTMR2.
RME-8 has been previously shown to regulate the endosomal
sorting of a variety of cargo at the early to late endosome interface,including the epidermal growth factor receptor (EGFR)
[14,17,18,20]. Similarly, in HeLa cells that were stimulated with
EGF, GFP-RME-8 displayed signiﬁcant co-localization with EGFR
(Fig. 6A). To ascertain the compartment where RME-8 and EGFR
co-localize we utilized triple staining immunoﬂuorescence with
the early endosome marker Rab5 (Fig. 6B) and the late endo-
some/lysosomal marker LAMP1 (Fig. 6C). Although EGFR was
found to partially co-localize with both of these markers, vesicles
containing EGFR and RME-8 only co-stained with Rab5 and not
LAMP1 suggesting that RME-8 co-localizes with EGFR on early
endosomes. Meanwhile, expression of MTMR2 S58A disrupted
the ability of RME-8 to co-localize with the EGFR (Fig. 6D). Again,
this disruption required the phosphatase activity of MTMR2 as
RME-8 was capable of co-localizing to EGFR positive vesicles in
the presence of the catalytically inactive mutant of MTMR2
(Fig. 6E). Collectively, these results demonstrate that MTMR2 reg-
ulates the PI(3)P dependent targeting of RME-8 to EGFR-positive
early endosomes.
In conclusion, our results have elucidated a novelmechanism for
regulating RME-8 endosomal targeting. As RME-8 in a variety of
organisms has clearly demonstrated to be a critical regulator of
endosomal processing, determining the temporal and spatial details
of how PI(3)P regulates the docking of RME-8 to endosomal vesicles
will deepen our understanding of the speciﬁc role of RME-8 in vesic-
Fig. 4. Deletion of the N terminal region of RME-8 abolishes RME-8-PI(3)P association. Hek 293 cellular lysates expressing GFP-RME-8 variants were subjected to a PI(3)P
pulldown (A) or a PI(3,5)P2 pulldown (B) as described in Materials and Methods and analyzed by immunoblotting using a GFP antibody. Immunoblots representative of three
independent trials are shown. GFP-RME-8 variants included full length GFP-RME-8, GFP-RME-8N453 and GFP-RME-8C425.
Fig. 5. MTMR2 S58A alters the endosomal localization pattern of RME-8. (A) HeLa cells were transiently transfected with FLAG-MTMR2 S58A or FLAG-MTMR2 S58A.C417S
and GFP-RME-8 and analyzed by immunoﬂuorescence microscopy. Alteration of the localization pattern of GFP-RME-8 is observed when co-expressed with FLAG-MTMR2
S58A (A, upper panel) or when cells are treated with wortmannin (B). Images were collected using 63 objectives. The scale bar represents 10 lm.
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malian tissues [17], it will also be interesting to investigate if other
MTMRs can regulate RME-8 to the same extent as MTMR2. Finally,
as CMT4B1 is caused by loss of a functional MTMR2, our ﬁndings
open the door to examining if RME-8 is overactive and contributes
to the demyelination phenotypes in CMT 4B1.Acknowledgments
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Fig. 6. GFP-RME-8 co-localization with EGFR on early endosomes is disrupted by MTMR2 S58A. HeLa cells were transiently transfected with GFP-RME-8, serum starved for
two hours and then stimulated with EGF (20 ng/ml) for 15 min. Cells expressing GFP-RME-8 alone (A–C) or co-expressing MTMR2 S58A (D), or MTMR2 S58A.C417S (E) were
analyzed by immunoﬂuorescence microscopy. Cells were probed for endogenous EGFR and GFP-RME-8 co-localization with the early endosome marker Rab5 (B) or late
endosome/lysosomal marker LAMP1 (C). Arrowheads represent vesicles displaying signiﬁcant co-localization. Images were collected using 63 objectives. The scale bar
represents 15 lm.
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